Gail M. Farfel

Companies

• DURECT CORPBoard member Apr 25, 2019 to now¹
• ProMIS Neurosciences Inc.Board member Aug 25, 2023 to Aug 25, 2023²
• ProMIS Neurosciences Inc.Chief executive officer Sep 20, 2022 to Aug 25, 2023³
• Tectonic Therapeutic, Inc.Board member Oct 21, 2020 to Jun 8, 2023⁴
• Zogenix (United States)EVP/Chief Development Officer Jul 6, 2015 to Mar 9, 2022⁵
• Marinus Pharmaceuticals (United States)Chief Clinical Dev.Regulatory Jul 31, 2014 to Apr 23, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PNProMIS Neurosciences Inc. PMN55,192 shares⁷$454.5K at $8.23Aug 23, 2023
• DDURECT CORP0 shares⁸Sep 11, 2025
• ZUZogenix (United States)0 shares⁹Mar 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2025U 15,500 shares of DURECT CORP⁸
• Sep 10, 2025Exercised options 5,500 shares at $1.22 of DURECT CORP¹⁰
• Aug 23, 2023Granted 53,192 shares of ProMIS Neurosciences Inc.⁷
• Dec 14, 2022Bought 1,000 shares at $4.94 of ProMIS Neurosciences Inc.¹¹
• Dec 6, 2022Bought 1,000 shares at $5.70 of ProMIS Neurosciences Inc.¹²
• May 18, 2022Bought 29,911 shares at $0.41 of DURECT CORP¹³
• May 16, 2022Bought 25,300 shares at $0.39 of DURECT CORP¹³
• May 13, 2022Bought 9,250 shares at $0.40 of DURECT CORP¹⁴
• May 12, 2022Bought 1,500 shares at $0.39 of DURECT CORP¹⁴
• May 11, 2022Bought 9,950 shares at $0.40 of DURECT CORP¹⁴
• May 10, 2022Bought 4,250 shares at $0.40 of DURECT CORP¹⁵
• May 10, 2022Bought 2,339 shares at $0.41 of DURECT CORP¹⁶
• May 9, 2022Bought 17,500 shares at $0.39 of DURECT CORP¹⁵
• Mar 7, 2022U 16,606 shares of Zogenix (United States)⁹